Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas. [electronic resource]
Producer: 20020613Description: 376-84 p. digitalISSN:- 0360-3016
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- administration & dosage
- Astrocytoma -- drug therapy
- Brain Diseases -- etiology
- Carmustine -- administration & dosage
- Combined Modality Therapy
- Dose Fractionation, Radiation
- Drug Administration Schedule
- Female
- Glioma -- drug therapy
- Gliosarcoma -- drug therapy
- Humans
- Male
- Middle Aged
- Pilot Projects
- Survival Rate
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.